Skip to content

Clinical trials

Completed Carcinoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Status: Completed Country / region: Australia Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20071
20081
20092
20102
20123
20151
20162
20181
20192
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Amgen2
Merck Sharp & Dohme LLC2
Queensland Centre for Gynaecological Cancer2
Ariad Pharmaceuticals1
Australasian Gastro-Intestinal Trials Group1
Daiichi Sankyo1
GlaxoSmithKline1
Mateon Therapeutics1
MedImmune LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma20
Neoplasms9
Neoplasm Metastasis5
Adenocarcinoma4
Lung Neoplasms4
Carcinoma, Hepatocellular3
Pancreatic Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Fallopian Tube Neoplasms2
Lung Diseases2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.